Coffee lowers risk of Skin Cancer

December 2nd, 2011|

According to a research by American Association for Cancer Research, people who drink coffee are at a reduced risk of developing Basal Cell Carcinoma, the most common form of skin cancer. And the more they drink lesser the risk !!

Mexico plans world-class medical research hub

December 6th, 2009|

Mexico City has announced plans for what it hopes will be a world-class centre for biomedical and nano-medical research. To be called Campus Biometropolis, the city hopes the new centre will attract investment and become an "engine for the transformation" of Mexico's economy.


November 9th, 2009|

The pharmaceutical industry has witnessed major changes in 2009. Performance has been affected by factors like sluggish prescription trends, intensifying generic competition and limited phase III catalysts.

A 360 Degree Perspective for CEOs to drive Growth, Innovation and Leadership,

October 25th, 2009|

Companies seem to be hesitating in moving ahead as they wait for further improvements in the global economy. However, Frost & Sullivan believes that the best CEOs are already planning how their businesses will take advantage of the growth opportunities presented by the rebound.

Drug MNCs look at India as a market

October 6th, 2009|

The list of drug majors scouting for a suitable buy in India is long. But this time, the attraction is: India as a market, and not merely as an inexpensive destination to source and produce products, say consultants and lawyers observing the increased merger and acquisition (M&A) activity seen in the pharmaceutical space.

Strong dollar beats down pharma revenues

July 15th, 2009|

It's that time again: Earnings time. As you know, Johnson & Johnson and Abbott Laboratories reported earlier this week; today we have Baxter, Novartis, and Biogen Idec. So far it looks like a tough quarter for sales, with currency costs holding down revenues at some companies and new generic competition eating into others.  

US study wants India to allow frivolous patenting

June 28th, 2009|

Multinational drug makers seem hell bent upon forcing the government to alter the patent regulations in their favour.

Sun Pharma gets CNBC-TV18 & DHL’s ‘Outstanding Exporter 2008-09’ award

April 28th, 2009|

Sun Pharmaceutical, a Mumbai-based Rs 3350 crore pharmaceutical giant and India's fastest growing international speciality pharma company, has received award in Outstanding Pharmaceuticals, Healthcare & Life Sciences category at the 3rd DHL and CNBC-TV18 International Trade Awards 2008-2009. These awards recognise the efforts of organisations and individuals who have driven India's growth engine in global trade and taken 'Brand India' to the world.

Present Scenario of The Biotech Industry

April 16th, 2009|

Last year, the Biotech industry as a whole achieved much better performance than the market. Both the NASDAQ Biotech Index and AMEX Biotech Index outperformed all three major market indices (Dow Jones Industrial Average, NASDAQ Composite and S&P 500) in a large margin. The major indices declined as much as 40%. While NASDAQ Biotech Index declined only 12.6%, and AMEX Biotech Index was down 17.7%.

Healthcare M & A activity could be impacted by further FCPA enforcement

April 10th, 2009|

Merger and acquisition activity within the pharmaceutical and medical device industries will likely increasingly be impacted by an uptick in the enforcement of the Foreign Corrupt Practices Act (FCPA), attorneys told

Foreign loans did not work for Wockhardt

April 4th, 2009|

Pharma major, Wockhardt, has been in the news for a while. This was after a flurry of events. Its chairman Habil Khorakiwala resigned elevating his son, Murtuza Khorakiwala to the post of Managing Director.

Choking India’s generics exports

January 28th, 2009|

The EU and WHO are pursuing strategies that will have serious consequences for developing countries.

Be at Med-e-Tel 2009 to Meet a Highly Qualified eHealth Audience

January 11th, 2009|

1-3 April, 2009, LuxembourgAn extensive international program with participants from 50 countries in Europe and around the world will put your company and solutions in front of an audience that is looking to see and hear the latest developments in telemedicine and eHealth. Supported by the International Society for Telemedicine & eHealth, European Commission, World Health Organization, International Telecommunication Union, European Association of CyberTherapy & Rehabilitation, and a range of other associations, the Med-e-Tel event gathers European and global healthcare leaders and providers.

Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania

September 1st, 2008|

Abbott Fund’s joint effort with Baylor International Pediatric AIDS initiative will improve access to Health Care for children with HIV/AIDS.

Algeta’s pain palliation drug Alpharadin meets endpoint in phase II trial

September 1st, 2008|

Algeta ASA, the Norwegian cancer therapeutics company, announced that the primary objective of its BC1-03 phase-II pain palliation study was met. The study showed that even single doses of Alpharadin in patients with painful bone metastases could produce increasing clinical benefit with increasing dose.

Canada – First Notification of Compulsory Licence to Export

October 10th, 2007|

 Canada has become the first country,  to invoke a provision allowing it to export a cheap, generic version of patented AIDS drugs, the World Trade Organization to notify the TRIPS Council of the World Trade Organization (WTO) on the Implementation of Compulsory Licence  to export the medicines.

International organizations

September 9th, 2007|

International organizations and FDA plays important role in checking improving the quality of medicines in World Pharmaceutical market.

Indian pharma annual growth seen more than 15 percent

September 2nd, 2007|

The Indian pharmaceutical industry, which has made phenomenal progress in recent years, is expected to maintain an annual average growth of about 15-20 percent in the period between 2005 and 2010.  Pharmaceutical exports touched $4.7 billion in 2005-06. According to the Economic Survey 2006-07, the value of pharmaceutical output had grown to $12.4 billion in 2005-06 from a mere $1.1 billion in 1990.